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ABSTRACT
Examination of cadmium (Cd) toxicity and disulfiram (DSF) effect on liver was focused on oxidative stress
(OS), bioelements status, morphological and functional changes. Male Wistar rats were intraperitoneally
treated with 1mg CdCl2/kg BW/day; orally with 178.5mg DSF/kg BW/day for 1, 3, 10 and 21 days; and co-
exposed from 22nd to 42nd day. The co-exposure nearly restored previously suppressed total superoxide
dismutase (SOD), catalase (CAT) and increased glutathione peroxidase (GPx) activities; increased previously
reduced glutathione reductase (GR) and total glutathione-S-transferase (GST) activities; reduced previously
increased superoxide anion radical (O2) and malondialdehyde (MDA) levels; increased zinc (Zn) and iron
(Fe), and decreased copper (Cu) (yet above control value), while magnesium (Mg) was not affected; and
decreased serum alanine aminotransferases (ALT) levels. Histopathological examination showed signs of
inflammation process as previously demonstrated by exposure to Cd. Overall, we ascertained partial liver
redox status improvement, compared with the formerly Cd-induced impact.
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Introduction
The raising awareness of cadmium (Cd) toxicity derives from its
human carcinogenic effect (IARC Group 1) and ecotoxicological
impact that is of even greater concern due to its bioaccumulation
(biological half-life is up to 20 years)1,2. Cd is widely used in metal
industry and battery manufacturing. Occupational exposure
implies inhalation of dust and fumes, while public health risk is
related to the contaminated food intake (aquatic organisms and
leafy vegetables). Cigarette smoking increases Cd intake in
humans as tobacco leaves naturally accumulate high level of Cd
from the soil3,4. The target organ toxicity related to acute exposure
to Cd involves primarily lung, liver, kidney and testes, while
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immunotoxicity, osteotoxicity and tumor genesis follow prolonged
exposure. Cd imposes high binding affinity to sulfhydryl groups
(–SH). Thus, proteins and peptides containing –SH groups have
been found to be essential for its accumulation/deposition in target
tissues. Therefore, metallothioneins (MTs), proteins containing –SH
groups, are of great importance for Cd tissue retention, enabling its
long biological half-life in the body5.
Reports on Cd have demonstrated its competitive antagonism
with certain essential metals [copper (Cu), iron (Fe) and zinc (Zn)] for
metal-binding sites in metalloenzymes. Alteration of antioxidative
enzymes activities (where active metals become replaced with Cd)
contributes to oxidative stress (OS) development. Overproduction of
reactive species (RS) [including reactive oxygen and nitrogen spe-
cies (ROS and RNS) and other free radicals (FRs)] along with insuffi-
cient antioxidative mechanisms lead to impairment of cell function
and morphology including: oxidative injury of lipids, DNA and pro-
teins. Distressed cell antioxidative capacity and energy level lead to
cell signaling impairment and eventually cell death by apoptosis.
Also, Cd binding to cysteines –SH group of glutathione (GSH) shifts
cell redox balance towards the oxidative state6,7.
Disulfiram (DSF) has been used in aversive treatment of alco-
holism (since 1960s) and cocaine dependence (recently). Also, Cd
has been recognized as an antidote for nickel (Ni) and Cu poison-
ing8. Recent reports on DSF have demonstrated that its metabolite
copper-diethyldithiocarbamate (Cu-DDTC) imposes an anticancer
therapeutic effect9. Nucleophilic character of DDTC allows forma-
tion of stable lipophilic complex with essential metals (preferably
with Cu) and also with toxic metals (such as Cd)10–12. Detached
from antioxidant enzymes by Cd and/or chelating agent such as
DDTC, transition metals such as Fe, Cu, etc. may participate in
Fenton reaction, contributing to FRs overproduction and overall
OS development11. Given that DSFs principal metabolite, DDTC,
contains free –SH group, formation of Cd-DDTC was anticipated.
Thus, examination of Cd interference with GSH and GSH-associ-
ated antioxidant enzymes was intriguing during the individual
and/or parallel exposure to Cd and DSF.
Based on the Cd affinity for binding with –SH group containing
compounds, we presumed that DSF may improve hepatic disor-
ders accomplished by Cd, through interference with its metabolic
pathways. Thus, in this study we focused on OS and essential met-
als-associated pathways of Cd hepatotoxicity and DSF capability to
repair hepatic disturbances induced by Cd. Priority of our study
was to examine if and to which extent Cd and DSF (in individual
and/or parallel exposure) interfere with hepatic metal and redox
status and function. Thus, we measured liver concentration of
toxic Cd and essential metals such as: Cu, Fe, Zn, magnesium (Mg)
and selenium (Se), and activities of the corresponding antioxida-
tive metalloenzymes. Non-enzymatic OS parameters were also
included: malondialdehyde (MDA), superoxide anion radical (O2),
GSH, oxidized glutathione (GSSG) and GSSG/GSH ratio.
Furthermore, we examined liver function and histology under the
applied experimental settings.
Materials and methods
Animals
Experimental animals were treated according to the Guidelines
for Animal Study, No. 12032014/9 (Ethics Committee of the
Military Medical Academy, Belgrade, Serbia). The rats were
housed in cages under standardized housing conditions (ambi-
ent temperature of 23 ± 2 C, relative humidity of 55 ± 3% and a
light/dark cycle of 13/11 h) and had free access to standard
laboratory pellet food and tap water. All experiments were
performed after two weeks’ period of adaptation to laboratory
conditions, while the subsequent procedures were performed
between 9 a.m. and 1 p.m.
Experimental design
The experiment was conducted on male Wistar rats weighing in the
range of 220–250 g. Animals were randomly divided into control
group (intact group; n¼ 6), two major experimental groups: Cd-
and DSF-groups, related to individual exposure for 42 and 21 days,
respectively; and the experimental group co-exposed to Cd and
DSF. Cd subgroups (Cd1, Cd3, Cd10, Cd21, Cd31 and Cd42; n¼ 6/
subgroup) were exposed i.p. to 1mg CdCl2/kg BW/day and DSF
subgroups (DSF1, DSF3, DSF10, DSF21; n¼ 6/subgroup) were
exposed orally to 178.5mg DSF/kg BW/day for the corresponding
time intervals. Rats co-exposed to Cd and DSF received i.p. 1mg
CdCl2/kg BW/day for 42 days, whereas per os intake of 178.5mg
DSF/kg BW/day was introduced from the 22nd day of exposure to
Cd and continued for the next 21 days (Cd22þDSF1, Cd24þDSF3,
Cd31þDSF10, Cd42þDSF21; n¼ 6/subgroup). The animals were
anesthetized with intraperitoneal injection of 50mg Na-pentobar-
bital/kg B.W. prior to being sacrificed by decapitation. Immediately
removed liver was weighed and stored at 80 C until analysis.
Chemicals
Sodium pentobarbital Vetanarcol (0.162 g/ml) was obtained from
Werfft-Chemie (Vienna, Austria). Glutathione in reduced form
(98–100% purity) and oxidized form (99% purity) was obtained
from Sigma-Aldrich Chemie (Steinheim, Germany), as well as
orthophosphoric (OPA) and metaphosphoric acid (MPA). Sodium
perchlorate monohydrate (NaClO4H2O) was obtained from Acros
Organics (Morris Plains, NJ). All sodium perchlorate solutions used
as mobile phase were filtered, prior to use, through 0.45 lm cellu-
lose filter membranes purchased from Agilent Technologies
(Waldbronn, Germany). Ethylenediaminetetraacetic acid (EDTA)
was obtained from Sigma-Aldrich (St. Louis, MO), whilst sodium
phosphate – Na2HPO4, potassium dihydrogen phosphate –
KH2PO4, trichloroacetic acid and thiobarbituric acid were obtained
from Merck (Darmstadt, Germany). Nitrobluetetrazolium (NBT) and
epinephrine were obtained from Sigma-Aldrich (St. Louis, MO).
Ransod commercial kits were used for superoxide dismutase (SOD)
determination (RANDOX Laboratories, UK). Commercial kits, used
for glutathione reductase (GR) (catalog number GRSA), glutathione
peroxidase (GPx) (catalog number CGP1) and glutathione-S-trans-
ferase (GST) (catalog number CS0410) determination, were pur-
chased from Sigma (St. Louis, MO). Deionized water was prepared
at Hospital Pharmacy Military Medical Academy (Belgrade, Serbia).
Nitric (HNO3) and perchloric acid (HClO4) were obtained from
Sigma-Aldrich (St. Louis, MO). Paraformaldehyde was obtained
from Sigma-Aldrich, whilst hematoxylin and eosin were obtained
from Merck (Kenilworth, NJ).
Sample preparation protocol
Tissue preparation for glutathione determination
The liver slices were transferred into 1ml ice-cold saline solution
followed by addition of 1ml ice-cold MPA (5% w/v) for deprotein-
ization. Homogenization was performed twice with a Teflon pestle
at 800 rpm for 15min at 4 C (Tehnika Zelezniki Manufacturing,
Slovenia). Liver homogenates were immediately centrifuged at
4 C and 8000 rpm for 25min. The resulting supernatant was used
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for chromatographic analysis or stored at 20 C until analysis. All
tissue samples were kept on ice during the whole procedure.
Tissue preparation for superoxide anion radical, malondialdehyde
and enzyme assays determination
The liver tissue was transferred into 1ml of ice-cold buffered
sucrose (0.25mol/l sucrose, 0.1mmol/l EDTA in sodium–potassium
phosphate buffer, pH 7.2) and then homogenized twice with a
Teflon pestle at 800 rpm for 15min at 4 C (Tehnika Zelezniki
Manufacturing, Slovenia). Thereafter, homogenates were centri-
fuged at 3500 rpm for 15min at 4 C. Sonication was performed
with supernatants (3 cycles including 30 s of sonication with a 5 s
pause between cycles). The resulting supernatant was used for
analysis or stored at 80 C until analysis. All tissue samples were
kept on ice during the whole procedure.
Tissue preparation for metal analysis
Liver tissue (close to 1 g) was mineralized with a mixture of con-
centrated mineral acids, nitric (HNO3) and perchloric acid (HClO4)
(4:1; v/v). Following mineralization, dilution was performed with
10ml of 0.1 M HNO3.
Histopathological analysis
A portion of liver was fixed in 10% buffered formalin (pH 7.4),
processed for paraffin sectioning (5lm cross-sections) and exam-
ined by light microscopy after staining with hematoxylin (H) and
eosin (E)13. Images were acquired using a bright-light microscope
(Olympus, Tokyo, Japan) with 10–20 magnification. The morpho-
logical features of the stained sections were presented using
digital images. The histological analysis was performed with the
control, Cd21, Cd42, DSF21 and Cd42þDSF21 group.
Measurement of liver oxidative status
Parameters of oxidative status (GSH, GSSG, O2, MDA and activ-
ities of the following enzymes: GR, GPx, GST, SOD and CAT) were
measured in liver homogenates of Wistar rats after the treatments.
Malondialdehyde
A terminal product of lipid peroxidation (LPO), MDA was determined
spectrophotometrically by the method of Djukic et al.6. Following
incubation of MDA with thiobarbituric acid – TBA reagent (15% tri-
chloroacetic acid and 0.375% TBA, water solution) at 95 C and pH
3.5, absorbance of formed red colored complex was measured at
532 nm. The results were expressed as nmol MDA/mg proteins.
Superoxide anion radical
Content of O2 was determined with a spectrophotometric
method, based on the reduction of nitrobluetetrazolium – NBT to
monoformazan by O2. The yellow color of the reduced product
was measured at 550 nm14. The results were expressed as nmol
reduced NBT/mg proteins.
Superoxide dismutase activity
Activity of SOD was measured using a commercial SOD kit.
Spectrophotometric method is based on the reaction of super-
oxide radicals, generated by xanthine and xanthine oxidase (XOD),
with 2-(4-iodophenyl)-3-(4-nitrophenol)-5-phenyltetrazolium chlor-
ide (I.N.T.). The absorbance of red formazan dye was measured at
505 nm. The activity of SOD is represented by a degree of inhib-
ition and expressed as U SOD/mg proteins.
Catalase activity
Catalase (CAT) activity was determined according to the procedure
described by Beers and Sizer15. Disappearance of peroxide, due to
CAT catalyzed conversion of hydrogen peroxide (H2O2) into water
(H2O) and oxygen (O2), was measured spectrophotometrically at
240 nm (corresponds to the enzyme activity). The results were
expressed as U CAT/mg proteins. One unit of CAT decomposes
one micromole of H2O2 per minute under the specified conditions.
HPLC-UV determination of reduced (GSH) and oxidized (GSSG)
glutathione
GSH and GSSG were simultaneously measured with a high per-
formance liquid chromatography (HPLC-UV) method. An isocratic
chromatographic separation was carried out on ZORBAX Eclipse
AAA (4.6 150mm, 3.5lm) analytical column (Agilent
Technologies) set at a flow rate of 1ml/min, 40 C and 215 nm.
Mobile phase consisted of 100mM sodium perchlorate solution
(pH 2.8 adjusted with 0.1% ortho-phosphoric acid). Supernatant
was used for chromatographic analysis16. The results were
expressed in regard to protein status, as nmol GSH/mg proteins or
nmol GSSG/mg proteins. The GSSG/GSH ratio was also considered
for the interpretation of the results.
Glutathione reductase activity
GR activity assay, based on the reduction of GSSG into GSH by GR,
was used. GR required a donor of reducing equivalents – nicotina-
mide adenine dinucleotide phosphate (NADPH) for the reaction.
Additionally, reduction of DTNB [5,50-dithiobis (2-nitrobenzoic acid)]
into TNB [5-thio (2-nitrobenzoic acid)] by GSH was measured spec-
trophotometrically at 412 nm. The increase of absorbance (corre-
sponds to TNB formation) indicates GR activity. One unit of GR
activity corresponds to the reduction of 1lmol of DTNB into TNB.
The absorbance was read with the initial delay of 60 s and every
10 s thereafter to obtain 11 time points. The samples were prepared
according to the procedure specified in Section. ”Tissue preparation
for superoxide anion radical, malondialdehyde and enzyme assays
determination“. The results were expressed as U GR/mg proteins.
Glutathione peroxidase activity
GPx activity assay was based on the initial GSH depletion by GPx
catalyzed reaction (reduction of H2O2 into H2O), followed by a
subsequent GSSG recycling back to GSH (by GR) utilizing NADPH
as a cofactor. The decrease in NADPH absorbance at 340 nm is
indicative of GPx activity (since GPx is the rate limiting factor of
the coupled reactions). In order to block the CAT activity (H2O2 is
the substrate for both enzymes, GPx and CAT), NaN3 was added
into the reaction mixture. The absorbance was recorded with ini-
tial 15 s delay and every 10 s thereafter to obtain 6 time points.
The samples were prepared according to the procedure specified
in Section ”Tissue preparation for superoxide anion radical, malon-
dialdehyde and enzyme assays determination“. The results were
expressed as units of U GPx/mg proteins.
Glutathione-S-transferase
GST activity assay utilizes conjugation of the thiol group of GSH to
the 1-chloro-2-dinitrobenzene (CDNB), which results in an increase
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in the absorbance, proportional to the GST activity, at 340 nm. The
absorbance is read immediately after preparation of the reaction
tests, and every minute thereafter to obtain 6 time points. The
samples were prepared according to the procedure specified in
Section ”Tissue preparation for superoxide anion radical, malondial-
dehyde and enzyme assays determination“. The results were
expressed as U GST/mg proteins.
Protein determination
As results were expressed in regard to protein status, Lowry
method was used for protein determination with a bovine serum
albumin as a standard17.
Metal content
The measurement of metals was performed with atomic absorp-
tion spectrometry with air-acetylene flame (Analyst 200,
PerkinElmer). Metal standard solutions were prepared according to
the PerkinElmer Pure Atomic Spectroscopy Standard Guidelines
(NIST traceable CRM, AccuStandard). The absorption wavelengths
were set at 228.8 nm, 216.51 nm, 213.86 nm, 305.91 nm, 285.21 nm
and 196.03 nm for Cd, Cu, Zn, Fe, Mg and Se determination,
respectively. Metal contents were expressed as lg/g of wet tissue
(Cd, Cu, Zn, Fe, Mg) and ng/g of wet tissue (Se).
Serum aminotransferases analysis
Serum aspartate transaminase (AST) and alanine transaminase
(ALT) activities were measured by using IFCC method (without
addition of pyridoxal phosphate, at 37 C) on Advia 1200
Siemens biochemical analyzer. AST and ALT activities were
expressed as U/L.
Statistical analysis
One-way ANOVA and Tukey's post hoc multiple test was
used (software GraphPad Prism, version 5.01) for statistical
data analysis. Values are presented as the means ± standard
deviation. Differences were considered statistically significant
for p< 0.05.
Results
Changes in liver oxidative status (MDA, O2, GSH, GSSG, GSSG/
GSH and activities of the enzymes: GR, GPx, GST, SOD, CAT), dur-
ing individual and parallel exposure of rats to Cd (for 1, 3, 10, 21,
31 and 42 days) and DSF (for 1, 3, 10 and 21 days), are presented
in Tables 1, 2 and 3, respectively.
Changes in liver metal status (Cd, Cu, Zn, Fe, Mg, Se) during
individual exposure of rats to Cd (for 1, 3, 10, 21 and 42 days) and
DSF (for 1, 3, 10 and 21 days), as well as during co-exposure of
rats to Cd (for 22, 24, 31 and 42 days) and DSF (for 1, 3, 10 and
21 days), are presented in Table 4.
Aforementioned OS-parameters and metal status for 21st and
42nd day, both for single and combined exposure to Cd and DSF
are presented graphically (Figures 1–3).
Acquired images of stained liver sections of control and treated
groups (Cd21, Cd42, DSF21 and Cd42þDSF21) were used for
histological assessment (Figure 4(A–E)).
Table 1. Parameters of oxidative status in the liver of male Wistar rats exposed solely to Cd or DSF.
Groups Exposure (days)
OS parameters
MDA (nmol/
mg proteins)
O2 (nmol red NBT/
mg proteins) SOD (U SOD/mg proteins) CAT (U CAT/mg proteins)
Control 0 63.6 ± 7.16 67.3 ± 6.70 2.34 ± 0.174 279.2 ± 44.10
Cd 1 101.6 ± 17.62 116.4 ± 1.58 2.34 ± 0.325 351.7 ± 21.79
3 123.8 ± 17.77 127.9 ± 25.19 2.18 ± 0.416 327.9 ± 47.27
10 123.1 ± 8.95 134.4 ± 11.39 1.89 ± 0.264 300.0 ± 50.73
21 134.2 ± 5.68 139.5 ± 21.73 1.71 ± 0.145 209.8 ± 11.11
42 138.1 ± 2.45 179.2 ± 12.04 1.44 ± 0.286 168.21 ± 2.17
DSF 1 65.5 ± 11.51 131.8 ± 25.78 1.42 ± 0.135 196.7 ± 30.59
3 77.8 ± 11.44 146.1 ± 26.64 1.39 ± 0.133 336 ± 23.92
10 77.3 ± 3.31 311.3 ± 10.63 1.19 ± 0.018 434.7 ± 21.24
21 107.9 ± 10.03 672.6 ± 14.83 0.9 ± 0.0.072 515.7 ± 49.45
Label of statistical significance refers to comparison between the experimental groups and the control group (intact animals); Level of significance is labeled as fol-
lows: (p< 0.01), (p< 0.001), (p< 0.0001); Values are expressed as mean ± standard deviation of six separate analyses (n¼ 6).
Table 2. Parameters of glutathione cycle in the liver of male Wistar rats exposed solely to Cd or DSF.
Groups
Exposure
(days)
OS parameters
GSH (nmol/
mg proteins)
GSSG (nmol/mg
proteins)
GSSG/
GSH (ratio)
GR (U GR/mg
proteins)
GST (U GST/
mg proteins)
GPx (U GPx/
mg proteins
Control 0 32.8 ± 3.40 1.8 ± 0.08 0.05 ± 0.004 0.0024 ± 0.0001 0.0439 ± 0.0031 1.139 ± 0.0514
Cd 1 25.6 ± 2.57 2.1 ± 0.13 0.08 ± 0.011 0.0019 ± 0.0002 0.0430 ± 0.0072 1.282 ± 0.1310
3 23.5 ± 2.42 3.7 ± 0.31 0.16 ± 0.011 0.0019 ± 0.0001 0.0373 ± 0.0062 1.314 ± 0.1897
10 22.2 ± 3.99 4.7 ± 0.38 0.21 ± 0.050 0.0018 ± 0.0003 0.0173 ± 0.0025 1.620 ± 0.1783
21 18.3 ± 2.00 2.1 ± 0.13 0.11 ± 0.018 0.0017 ± 0.0002 0.0144 ± 0.0026 1.954 ± 0.1055
42 12.5 ± 2.56 1.7 ± 0.23 0.14 ± 0.012 0.0015 ± 0.0001 0.012 ± 0.0017 2.067 ± 0.0777
DSF 1 32.5 ± 5.46 4.2 ± 0.77 0.13 ± 0.028 0.0015 ± 0.0002 0.0450 ± 0.0057 1.228 ± 0.1469
3 21.7 ± 3.88 0.6 ± 0.06 0.03 ± 0.003 0.002 ± 0.0002 0.0578 ± 0.0037 1.344 ± 0.1530
10 38.0 ± 3.85 4.5 ± 0.34 0.12 ± 0.018 0.0029 ± 0.0001 0.0594 ± 0.0013 1.814 ± 0.0058
21 31.8 ± 4.89 0.7 ± 7.10 0.02 ± 0.007 0.0021 ± 0.0002 0.1096 ± 0.016 2.060 ± 0.2587
Label of statistical significance refers to comparison between the experimental groups and the control group (intact animals); Level of significance is labeled as fol-
lows: (p< 0.01), (p< 0.001), (p< 0.0001); Values are expressed as mean ± standard deviation of six separate analyses (n¼ 6).
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Activity of serum aminotransferases (AST and ALT) determined
at 21st and 42nd day, both for single and combined exposure to
Cd and DSF, are presented in Table 5.
Correlation of all measured parameters is presented in Table 6.
Discussion
Guided by the fact that patients addicted to both, alcohol and
nicotine, smoke more frequently due to cessation of drinking
when subjected to DSF therapy, we attempted to evaluate Cd
hepatotoxic effects (via peritoneal route) and to reveal if and to
which extent DSF interferes with Cd hepatotoxic pathways, focus-
ing on hepatic metal and redox status and function, using Wistar
rats as an animal model.
Individual and parallel subacute/subchronical exposure to Cd
and/or DSF resulted in Cu, Fe, Zn and Se increment in liver of the
exposed rats (in all experimental groups) (Figure 3(B,C,D,F)).
Additive increasing effect on hepatic Fe and Zn and moderate on
Cu and Se were documented in the co-exposed group, compared
with individual exposure to Cd and/or DSF.
Molecular pathway related to Cd hepatotoxicity encircles indir-
ect OS promotion due to increase of unbound Cu and Fe ions,
which participate (as transition metals, they participate in this
reaction in their lower oxidation state, i.e. reduced form: Cuþand
Fe2þ) with H2O2 in Fenton reaction and contribute to hydroxyl
radical (OH) production. Cd itself is not redox active18–20. The
other pathway includes disturbance of non-enzymatic (GSH and
the total sulfhydryl groups) and enzymatic antioxidants (SOD, CAT,
GPx) in the liver7,21,22. Thus, prooxidative effect of Cd was con-
firmed with the occurrence of antioxidative enzymes inhibition,
increase of LPO and detrimental effect on GSH-cycling. DSF itself
demonstrated confronting effects on hepatocellular redox buffer
system compared with previous report23. The effect on redox sys-
tem occurs as a result of nucleophilic character and metal binding
affinity of its principal metabolite, DDTC, which is a thiol contain-
ing compound.
In accordance with the literature, deleterious effects of Cd dur-
ing subacute/subchronic exposure on liver morphology and func-
tion were confirmed by our results24,25. While unable to conduct
an inhalation animal study (inhalation route of Cd exposure), we
administered Cd i.p. to male Wistar rats, since Cd delivery into the
blood stream is almost equal to inhalation route26,27. The applied
dose of 1mg CdCl2/kg/day was chosen according to the litera-
ture24,25, while per os dose of 178.5mg DSF/kg BW/day corre-
sponds to the lowest maintaining dose of 125mg per tablet given
in therapy of recovering alcoholics28,29.
Table 3. Parameters of oxidative status in the liver of male Wistar rats co-exposed to Cd and DSF.
OS parameters
Control
Group
CdþDSF
0 day 1 day 3 days 10 days 21 days
MDA 63.6 ± 7.16 132.4 ± 7.10 112.8 ± 10.51 103.1 ± 9.98 99.1 ± 11.64
O2 67.3 ± 6.70 140.9 ± 17.39 127.2 ± 12.4 127.1 ± 12.49 106.7 ± 10.97
SOD 2.34 ± 0.174 1.51 ± 0.277 2.13 ± 0.261 2.16 ± 0.081 2.27 ± 0.284
CAT 279.2 ± 44.10 245.4 ± 30.29 388.6 ± 57.69 221.7 ± 12.95 216.4 ± 3.35
GSH 32.8 ± 3.40 10.8 ± 1.94 26.5 ± 0.42 28.1 ± 4.24 16.3 ± 2.35
GSSG 1.8 ± 0.08 1.9 ± 0.22 1.9 ± 0.27 1.3 ± 0.01 1.1 ± 0.09
GSSG/GSH 0.05 ± 0.004 0.19 ± 0.049 0.07 ± 0.01 0.05 ± 0.007 0.07 ± 0.014
GR 0.0024 ± 0.1 0.0014 ± 0.01 0.0028 ± 0.4 0.0029 ± 0.3 0.0026 ± 0.5
GST 0.0439 ± 0.00306 0.087 ± 0.00502 0.087 ± 0.01097 0.0876 ± 0.01679 0.0893 ± 0.00115
GPx 1.139 ± 0.0514 2.656 ± 0.001 1.852 ± 0.0704 1.837 ± 0.0025 1.157 ± 0.0037
Label of statistical significance refers to comparison between the experimental groups and the control group (intact animals); Level of significance is labeled as fol-
lows: (p< 0.01), (p< 0.001), (p< 0.0001); Values are expressed as mean ± standard deviation of six separate analyses (n¼ 6); 21-day period refers to adminis-
tration of DSF for 21 days in the combined treatment; Units of OS parameters are expressed as: MDA (nmol/mg proteins), O2 (nmol red NBT/mg proteins), SOD (U
SOD/mg proteins), CAT (U CAT/mg proteins), GSH (nmol GSH/mg proteins), GSSG (nmol GSSG/mg proteins), GSSG/GSH ratio, GR (U GR/mg proteins), GST (U GST/mg
proteins), GPx (U GPx/mg proteins).
Table 4. Metal content in the liver of male Wistar rats.
Groups Exposure (days)
Metal
Cd Cu Fe Zn Mg Se
Control 0 / 3.3 ± 0.28 66.0 ± 12.12 37.5 ± 4.44 240.2 ± 17.35 15.2 ± 0.39
Cd 1 55.8 ± 5.48 5.6 ± 0.93 69.4 ± 9.53 54.4 ± 8.68 240.5 ± 22.62 41.9 ± 1.95
3 54.22 ± 9.43 5.3 ± 0.43 58.5 ± 7.32 58.1 ± 5.47 240.0 ± 11.21 32.2 ± 4.97
10 57.5 ± 8.68 6.3 ± 0.38 77.3 ± 10.21 78.1 ± 6.66 261.9 ± 48.31 28.4 ± 1.13
21 107.3 ± 5.93 l 8.4 ± 1.64 87.0 ± 7.03 96.7 ± 12.59 239.7 ± 31.11 22.6 ± 2.44
42 166.5 ± 26.3 l 8.7 ± 1.19 138.5 ± 11.95 96.3 ± 16.94 242.0 ± 29.96 /
DSF 1 / 3.9 ± 0.62 64.2 ± 11.65 42.5 ± 3.53 242.8 ± 19.45 18.5 ± 0.52
3 / 5.6 ± 0.97 57.5 ± 9.50 67.9 ± 11.44 244.4 ± 24.41 34.9 ± 6.44
10 / 5.7 ± 1.18 62.1 ± 6.87 69.3 ± 12.38 233.8 ± 34.33 43.6 ± 7.78
21 / 9.0 ± 1.74 100.1 ± 14.31 65.6 ± 6.39 219.7 ± 16.80 44.8 ± 8.13
CdþDSF 1 133.0 ± 19.46 l 5.7 ± 0.73 94.7 ± 13.34 108.6 ± 7.31 241.6 ± 16.61 22.0 ± 0.61
3 106.6 ± 13.8 l 13.9 ± 1.61 94.4 ± 6.23 114.3 ± 11.23 230.6 ± 7.72 22.3 ± 3.14
10 152.2 ± 29.48 l 9.4 ± 1.48 102.4 ± 10.68 145.5 ± 9.87 241.2 ± 14.37 23.3 ± 2.03
21 235.3 ± 11.46 l 5.6 ± 0.29 197.6 ± 11.50 156.1 ± 14.21 242.5 ± 31.55 24.2 ± 0.99
Significances between experimental groups in essential metal content determination refer to comparison between the experimental groups and the control group
(intact animals); Significances between experimental groups in Cd content determination refer to comparison between the experimental groups and Cd1 subgroup
(l); Level of significance is labeled as follows: (p< 0.01), (p< 0.001), (p< 0.0001); Values are expressed as mean ± standard deviation of six separate analyses
(n¼ 6); 21-day period refers to administration of DSF for 21 days in the combined treatment; Units of metals are expressed as lg/g tissue for Cd, Cu, Fe, Zn, Mg and
ng/g tissue for Se.
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Initial retention of Cd in hepatocytes (Figure 3(A)) is in agree-
ment with the literature30,31. The highest accumulation of Cd
occurred in liver of rats co-exposed to Cd and DSF, probably as a
result of DSF enterohepatic circulation and formation of Cd-DDTC,
indicating that canalicular transport of Cd in hepatocytes may be
linked to biliary GSH excretion7. This occurrence actually indicates
an increased risk for liver health status in alcoholic-smokers under-
going DSF therapy. Cd accumulates in cells due to its affinity for
binding to –SH groups of small peptides and proteins, such as
GSH or metallothioneins (MT-I and MT-II, which expression is also
incited by Cd). Confirmed time-dependent Cd liver deposition cor-
responds to augmentation of hepatic injury documented micro-
scopically (Figure 4(B,C))2,32.
Reported Cd toxicity pathways include alteration of thiol pro-
teins and antioxidant enzymes activity, inhibition of energy metab-
olism and DNA structure disruption33. Metalloproteins functionality
critically depends on the corresponding essential metals level (Cu,
Fe, Zn, Se, etc.) in close vicinity. Ion exchange between Cd and
essential metals in active sites of the metalloenzymes ultimately
leads to their inhibition. In fact, that particular often proposed
molecular mechanism of Cd hepatotoxicity was confirmed with
our results7. The exposure to Cd resulted in significant increase of
Cu, Fe, Zn (p< 0.0001) and Se (p< 0.01) in liver (Figure 3(B,C,D,F),
Table 4). As expected, gradual decrease of SOD activity (Cu is
coordinately bound to four histidine residues in SOD) occurred in
Cd group (Figure 1(C)). The high metal binding affinity of thiols
was confirmed with Cu-DDTC formation in DSF group34. Moreover,
increased Cu and Zn content in the liver of rats exposed individu-
ally to Cd and DSF might be explained by initiated MTs expression
that also requires the release of Cu from plasma ceruloplasmine35.
Cd has the affinity to displace Zn from MTs36, while DDTC causes
oxidation of cysteine residues from MTs to cystine (due to capture
of generated harmful oxidant radicals), which could lead to liber-
ation of bound metal ions (Cu, Zn, Se)37, as seen in our results
(Figure 3(B,D,F)). The interchanging between Cu/Zn and Cd,
whether it takes place in SODs active site, MTs or complexes with
DDTC (Cu-DDTC and Cd-DDTC), is likely the mechanism of action
under the Cd and DSF co-exposure38. Initial increase in Se (by
175% on the first day; p< 0.0001) was in accordance with the
reported Se redistribution from other tissues into liver upon
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Figure 1. Representative graphs of oxidative status in liver of Wistar rats intact and administered Cd, DSF and a combination of both substances. See the experimen-
tal conditions presented in the section Experimental design. Values are presented as means ± S.D. Labels of statistical significance: compared with the control group ()
and compared with Cd42 subgroup (). Statistical significance was considered at: *p< 0.01, **p< 0.001, ***p< 0.0001 and p< 0.0001. (A) Superoxide anion radical
content (O2): presented parameter of OS (expressed as nmol red NBT/mg proteins). (B) Lipid peroxidation: parameter of OS presented as MDA level (expressed as
nmol MDA/mg proteins). (C) SOD activity: presented parameter of antioxidative defence (expressed as U SOD/mg proteins). (D) CAT activity: presented parameter of
antioxidative defence (expressed as U CAT/mg proteins).
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exposure to Cd. Selenium content gradually decreased by the 21st
day due to formation of Cd–Se–protein complexes (similarly to
MTs) and it remained by 49% above the control value (p< 0.01)39.
Significant Se increase in DSF group (p< 0.0001) may be explained
via induction of MT, as it was the case with Zn31. Similar Se con-
tent obtained in Cd and co-exposed groups, was in both cases
higher than the controls (Cd21: p< 0.01, Cd42þDSF21 p< 0.001)
(Figure 3(F), Table 4).
Time-dependent increase in Fe was achieved in all experimen-
tal groups (Cd21, Cd42: p< 0.0001 and DSF21: p< 0.0001),
whereas additive effect was accomplished in co-exposed group
(Figure 3(C), Table 4). Increased Fe level contributes to OS devel-
opment through Fenton-like reactions40. Previous reports on Cd
exposure alluded that Fe increase possibly occurs due to its
replacement by Cd from various membrane and cytoplasmic pro-
teins, such as ferritin and iron–sulfur clusters in Fe–S proteins41.
Some authors reported controversial Cd effect on Fe, its decrease
actually42. As Cd binds to sulfhydryl groups (with higher affinity
than phosphate, chloride, carboxyl, or amino groups), the inactiva-
tion of key thiols affects different important biological processes
i.e. causes a number of deleterious effects7.
Mg content was not significantly changed in any of the applied
treatments (Figure 3(E), Table 4).
Antioxidative enzyme SOD converts O2 into H2O2 and exits
in three different forms: intracellular Cu/Zn SOD (in cytosol and
nucleus) and manganese (Mn) SOD (MnSOD) (in mitochondria)
and an extracellular Cu/Zn-containing SOD (ecSOD), also known
as SOD1, 2 and 3, respectively7. Total SOD (tSOD) activity
represents the sum of all three isoforms. Gradual decline of
tSOD activity (Cd21, Cd42, DSF21: p< 0.0001) (Figure 1(C), Table
1) along with instant and gradual increase of O2 (Cd21, Cd42,
DSF21: p< 0.0001) (Figure 1(B), Table 1) was documented in Cd
and DSF groups, which resulted in insufficient sequestration
of O2.
Cd causes perturbation of the cytosolic and mitochondrial SOD
enzyme topography by reversible binding to –SH groups of cyst-
eine residues and by replacement of Cu and/or Mn in the active
site of Cu/Zn SOD and/or MnSOD, respectively. Reduced Cu/Zn
SOD activity in DSF group was a consequence of Cu-DDTC forma-
tion43–45. By the end of the co-exposure, tSOD activity was almost
equal to the controls, despite documented markedly high O2
level. Assumable, the reaction between DDTC and Cd prevailed
the reaction of Cu-DDTC formation, allowing SOD restauration
(compared with Cd42 group, tSOD activity was significantly higher
in Cd42þDSF21 group, p< 0.0001) (Figure 1(C), Table 3).
Increased O2 may be addressed to its overproduction through-
out several pathways, including: (a) intramolecular radical cycling
of thiols (including GSH, DDTCs, etc.), which results in an overpro-
duction of thiyl radicals (GSS) and O2 (O2 was in negative
correlation with GSSG in Cd42 and DSF groups) (Table 6); (b) acti-
vation of Kupffer cells by Cd-mediated liver injury; (c) ALDH inhib-
ition46,47; and (d) both Cd and DSF interfere with hepatic P450IIE1
enzyme, which could explain GR activity status in all experimental
groups45,46,48. As Cd induces hepatic P450IIE1, it may reduce avail-
ability of nicotinamide adenine dinucleotide phosphate (NADPH)
to donate reduction equivalents to GR, thus decreases GR
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Figure 2. Representative graphs of glutathione cycle in liver of Wistar rats intact and administered Cd, DSF and a combination of both substances. See the experimen-
tal conditions presented in the section Experimental design. Values are presented as means ± S.D. Labels of statistical significance: compared with the control group ()
and compared with Cd42 subgroup (). Statistical significance was considered at: *p< 0.01, **p< 0.001, ***p< 0.0001 and p< 0.0001. (A, B) Reduced and oxidized
glutathione content: presented parameters of antioxidative defence (obtained values, expressed in lM, were recalculated in regard to protein status and expressed as
nmol GSH or GSSG/mg proteins for the appropriate discussion of the obtained results). (C) Ratio of oxidized and reduced glutathione: presented parameter of glutathi-
one homeostasis (values are presented as means of GSSG/GSH ratio through chosen time points). (D) GR activity: presented parameter of antioxidative defence
(expressed as U GR/mg proteins). (E) GST activity: presented parameter of antioxidative defence (expressed as U GST/mg proteins). (F) GPx activity: presented parameter
of antioxidative defence (expressed as U GPx/mg proteins).
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activity46. On the contrary, through inhibition of hepatic P450IIE1,
DSF prevents/reduces CYP2E1-mediated xenobiotic toxicity and
consequent formation of O2, i.e. initiation of a radical chain reac-
tion and OS development49.
According to the literature, an instant incline of MDA occurred
in Cd groups (Cd21, Cd42: p< 0.0001) (Figure 1(A), Table 1)7.
Also, significantly higher hepatic MDA levels were obtained in DSF
and co-exposed group (DSF21 and Cd42þDSF21: p< 0.0001; 56%
higher than the controls) (Figure 1(A), Tables 1 and 3). Lipid perox-
idation was significantly lower in co-exposed group than in the
Cd42 group (p< 0.0001), alluding to the partially protective effect
of DSF.
Gradual decrease of CAT with the time (Cd21: p< 0.001; Cd42:
p< 0.0001; and Cd42þDSF21: p< 0.01) (Figure 1(D), A.1, 3 Tables 1
and 3) occurred probably due to Cd binding to imidazole residue of
His-74 in CAT50, implicating insufficient transformation of H2O2 into
H2O. It is well-known that GPx converts H2O2 into H2O and add-
itionally, lipid hydroperoxides (ROOH) into alcohols (ROH)51.
Accumulation of non-processing H2O2 leaves the possibility of its
homolytic cleavage into HO, which instantly initiates LPO.
Moreover, increased content of Fe and Cu in those groups supports
the contribution of Fenton reaction in HO formation (the reaction
between transition metals and H2O2), supporting LPO progression
(what was confirmed by our experiment)6. CAT activity was only
elevated in DSF group (p< 0.0001). Averting of O2 sequestration
by significantly reduced SOD (the lowest in DSF21 group) implies
decreased H2O2 production, thus it remains unclear why CAT activ-
ity was extremely high only in this experimental group52.
We showed that incline of LPO was independent of GPx activity
(in all experimental groups). Individual treatments with Cd and
DSF resulted in gradual increase in GPx activity (Cd21, Cd42 and
DSF21: p< 0.0001) (Figure 2(F), Table 2), opposing previous reports
on Cd effect on GPx7. Moreover, increased GPx activity in DSF21
group may be related to the reported DDTC peroxidase-like
activity (it donates electron in the reaction catalyzed by GPx)53.
The co-exposure to DSF and Cd lead to a gradual decrease of GPx
activity up to the control values, after initial increase seen on the
first day, which was accordingly significantly lower compared with
Cd42 group (p< 0.0001) (Figure 2(F), Table 3). Opposed activities
of GPx (significantly high) and SOD (significantly low) were accom-
plished in Cd and DSF groups.
Decreased hepatic GST activity upon Cd exposure was con-
firmed in animal studies7,21,42. Accordingly, we obtained similar
results that can be explained by Cd binding to GSH, which is the
substrate for GST6. Gradual decline of GST activity (Cd21:
p< 0.0001; Cd42: p< 0.0001) upon Cd exposure was in relation
with significant GSH depletion, confirming strong binding affinity
between Cd and –SH group of GSH (Cd21, Cd42 and Cd42þDSF21
group: p< 0.0001) (Tables 2 and 3, Figure 2(A)). On the contrary, in
the individual and parallel exposure to DSF, GSH was not affected
and was accompanied with increased GST activity (DSF21,
Cd42þDSF2: p< 0.0001) (Figure 2(E), Tables 2 and 3), pointing out
predominant Cd-DDTC formation over Cd–(GS)2 complex
2.
Glutathione is a substrate for GST and donor of reducing equiv-
alents in GPx catalyzed reaction (reduction of ROOH and H2O2,
when GSH becomes oxidized into GSSG). It is also of great import-
ance in toxic metals detoxification reactions38. Elevated GPx activ-
ity explains increase of GSSG and LPO in Cd groups. Additionally,
significantly low GST activity in groups individually treated with
Cd, indicates that GSH depletion is not on the account of thiolisa-
tion reactions (Figure 2(A,B,E,F)). It has been reported that GST
catalyzes thiolisation of LPO terminal products and imposes
Cd
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Figure 3. Representative graphs of metal content in liver of Wistar rats intact and administered Cd, DSF and a combination of both substances. See the experimental
conditions presented in the section Experimental design. Values are presented as means ± S.D. Labels of statistical significance for toxic metal Cd: compared with the
Cd1 group () and compared with Cd42 subgroup (). Labels of statistical significance for essential metals (Cu, Fe, Zn, Mg, Se): compared with the control group ()
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(expressed as lg Cd/g liver tissue). (B) Cu content (expressed as lg Cu/g liver tissue). (C) Fe content (expressed as lg Fe/g liver tissue). (D) Zn content (expressed as
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GSH-peroxidase activity over ROOH48,51. Apparently, increased LPO
in Cd groups may be explained by inappropriate conversion of
ROOH by GST6. Disruption of glutathione homeostasis is actually
considered to be a key element in Cd-induced hepatotoxicity7.
Lipid peroxidation did not develop on the account of GSH deple-
tion in DSF groups, individual or parallel treatment (Figures 1
and 2), confirming strong supportive role of DSF in glutathione
cycle antioxidative defense.
Also, GSH is a prime thiol-disulphide redox buffer in cells,
important for maintaining GSSG/GSH ratio balance. Flavoprotein
GR catalyzes GSSG reduction back into GSH by using NADPH as a
donor of electrons. Oxidized glutathione was the lowest in DSF
treated groups during individual and parallel exposure (DSF21,
Cd42þDSF21: p< 0.0001) (Figure 2(A,B), Tables 2 and 3), indicat-
ing suppressed depletion of GSH on the account of GSSG forma-
tion. Oxidation of GSH occurs in reactions where GSH is donor of
reducing equivalents (such as reaction catalyzed by GPx). These
results are in line with GSSG/GSH ratio profile and decreased GR
activity (Figure 2(C,D)) in DSF group. Moreover, insufficient GSSG
turnover into GSH by gradually decreased GR activity occurred in
Cd groups (Figure 2(A,D)) (Cd21: p< 0.001 and Cd42: p< 0.0001),
which is consistent with the previous reports on Cd-induced GR
inhibition7. Observed inconsistency in GSSG/GSH ratio within 21
days of DSF treatment might be related to changes in relation of
DSF to DDTC, hence, DSF and DDTC constitute a redox couple
active in biological medium (Table 2) (concomitant depletion of
DDTC occurred through metal binding and thiolation reactions
during daily exposure to DSF, for 21 days)54. Nevertheless, GSSG/
GSH ratio in DSF group was significantly lower than in the controls
(four times), while in Cd42þDFS21 that value was almost double
lower than in Cd42 group, indicating protective role of DSF in
terms of keeping GSH reserves (Figure 2(C)). Our results are in
accordance with previous reports on DDTC protection against Cd-
induced hepatotoxicity afforded by DDTC chelates formation,
although of low therapeutic importance because of rapid break-
down of the complex55.
Macroscopically, individual and prolonged exposure to Cd lead
to liver enlargement and ischemia compared with the control,
which is consistent with previous reports on Cd-induced liver
inflammation processes that involve Kupffer cells activation and
neutrophil infiltration28. Cd treatment also caused an increase in
serum aminotransferases (AST and ALT) (Table 5), probably causing
substantial leakage of hepatic enzymes into the bloodstream21,56.
On the other hand, DSF treatment did not affect serum amino-
transferases activity (Table 5), which is not in line with the previ-
ous reports on moderately elevated aminotransferases serum level
Cd42Control
DSF21 Cd42+DSF21
Legend:
N -infiltration of neutrophils
F –focal necrosis
NS -neutrophil infiltration of sinusoids
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Figure 4. Representative photomicrographs of liver sections from Wistar rats exposed i.p. to 1mg CdCl2/kg BW/day (for 21 and 42 days) and orally to 178.5mg DSF/kg
BW/day (for 21 days), individually and/or in combination: (A) Control/intact group, showing normal appearance; (B) Cd21: showing infiltration of neutrophils (N) and
focal necrosis (F). (C) Cd42: showing infiltration of neutrophils (N) and neutrophil infiltration of sinusoids (NS). (D) DSF21: showing normal appearance; and (E) Cd42 þ
DSF21: group showing infiltration of neutrophils (N), neutrophil infiltration of sinusoids (NS) and focal necrosis (F).
Table 5. Serum aminotransferases analysis in male Wistar rats.
Parameter
Groups
Control Cd Cd DSF CdþDSF
0 day 21 days 42 days 21 days 21 days
AST (U/L) 148 ± 15.8 184 ± 8.2¥ 230 ± 31.7¥ 136 ± 16.2 302 ± 2.5¥;£
ALT (U/L) 27 ± 0.6 42 ± 3.3¥ 46 ± 3.2¥ 28 ± 3.0 37 ± 2.6¥;£
Significances between experimental groups are labeled as follows: compared with controls (¥); compared with Cd42 subgroup (£);
Level of significance is labeled as follows: (p< 0.001), (p< 0.0001); Values are expressed as mean ± standard deviation of six separ-
ate analyses (n¼ 6); 21-day period refers to administration of DSF for 21 days in the combined treatment.
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during chronic DSF exposure57. The co-exposure to DSF and Cd
resulted in decreased serum ALT activity, compared with Cd42
group (p< 0.0001), indicating protective role of DSF and reversible
character of hepatic tissue injury induced by Cd previously.
Histopathological examination of liver from intact rats showed
normal structure/microarchitecture of liver tissue (Figure 4(A)).
Examination of liver from Cd21 and Cd42 groups, showed infiltra-
tion of neutrophils, which indicates the presence of inflammation
(Figure 4(B,C)). Inflammation process is consistent with previous
reports22,56,58. Focal necrosis is also present in Cd21 group
(Figure 4(B)), which is consistent with previous report indicating
appearance of hepatic necrosis at the similar applied i.p. dose of
CdCl2
59. Fat globules and signs of cytoplasmic vacuolization
(nucleus shifted peripherally), which also appeared, indicate toxic
damage of hepatocytes. Higher grade of neutrophil infiltration was
observed in the Cd21, compared with the Cd42 group. As previ-
ously reported, repeated exposure to Cd causes acute and nonspe-
cific chronic inflammation in parenchyma and portal tract58.
Additionally, hepatic sinusoids enlargement and neutrophil infiltra-
tion of sinusoids were observed in Cd42 group.
Initial damage following exposure to Cd may be caused by a
disturbance in thiol homeostasis and/or the production of ROS,
what is in accordance with previous report indicating that Cd
induces a decrease in GSH level in epithelial cells60. One of the
possible resulting effects is an increased susceptibility to influ-
enza viral infection, as Cd-induced OS directly increases the abil-
ity of influenza virus to replicate in the host-cell. Thus, exposure
to Cd could be considered as a risk factor for individuals
exposed to a greater extent to the contaminant. Further on, liver
injury occurs from inflammatory processes initiated by activation
of Kupffer cells, which release chemoattractants and activators of
neutrophils, resulting in neutrophil influx and tissue damage. Cd
interacts with vascular endothelium which leads to ischemic
damage to surrounding hepatocytes. Apart from infiltration of
neutrophils, hemorrhage was not shown at the applied dose
of Cd61.
Examination of DSF21 group showed normal structure/micro-
architecture of liver tissue (Figure 4(D)). Combined treatment,
Cd42þDSF21, resulted in minor infiltration of neutrophils and
neutrophil infiltration of sinusoids, along with a slight sign of focal
necrosis (Figure 4(E)). Combined treatment showed decrease of
inflammatory infiltrate but still signs of focal necrosis compared
with Cd21 group, while it remains unclear why Cd42 group
showed no signs of necrosis. What is certain is that individual
treatment with DSF does not disturb liver tissue,
Conclusions
In this study, we confirmed harmful hepatic effect of Cd, in terms of
disrupted redox and metals status and aminotransferases level,
although possibly of reversible character at the applied i.p. sub-
chronic exposure. DSFs partially protective role against Cd-associ-
ated hepatic oxidative disorders was documented by redox status
improvement achieved in Cd42þDSF21 groups, compared with
Cd42 group, with an emphasis on preserving GSH reserves.
Therefore, obtained results are of the great importance and may
indicate DSFs beneficial effects against Cd induced OS-associated
hepatic disorders in recovering alcoholic-smokers on DSF treatment.
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Se GPx GR Mg
Spearman r 0.9429 0.9429 0.971 0.8857
p Value 0.0167 0.0167 0.0028 0.0333
Cd21 SOD GPx
GPx MDA
Spearman r 0.9276 0.2899
p Value 0.0167 0.0167
Cd42 MDA SAR SOD GST
Cd GSSG GSSG/GSH Mg
Spearman r 0.9429 0.9429 0.8533 0.8827
p Value 0.0167 0.0167 0.0333 0.0333
DSF21 SAR GSSG GSSG/GSH GPx
GSSG GPx Zn Zn GST MDA Zn
Spearman r 0.8697 0.9429 1 0.8697 0.8452 0.9429 0.9429
p Value 0.0333 0.0167 0.0028 0.0333 0.0333 0.0167 0.0167
Cd42 þ DSF21 MDA SAR SOD CAT GSH GSSG
SOD GR Zn GSH GR Fe MDA GR MDA GR
Spearman r 0.8857 0.9856 0.8986 0.9429 0.9276 0.8857 0.9429 0.9856 0.8986 0.8676
p Value 0.0333 0.0028 0.0333 0.0167 0.0167 0.0333 0.0167 0.0028 0.0333 0.0333
Correlation was calculated between all parameters across all chosen time points (Cd: 21 and 42 days; DSF: 21 days and Cd 42 days and DSF 21 days of co-exposure)
in Wistar rats i.p. receiving 1mg CdCl2/kg/day and orally 178.5mg DSF/kg BW/day. Spearman correlation coefficient (r)>± 0.70 was the criteria for the segregation
of the results. The units of the presented parameters are as follows: malondialdehyde (MDA): nmol MDA/mg proteins; superoxide anion radical (SAR): nmol red NBT/
min/mg proteins; superoxide dismutase (SOD): units of SOD/mg proteins; catalase (CAT): units of CAT/mg proteins; glutathione – reduced and oxidized (GSH and
GSSG): nmol of GSH and GSSG/mg proteins; glutathione reductase (GR): units of GR/mg proteins; Glutathione-S-transferase (GST): units of GST/mg proteins; glutathi-
one peroxidase (GPx): units of GPx/mg proteins; and concentration of metals – iron (Fe): lg of Fe/g of wet tissue and selenium (Se): ng of Se/g of wet tissue.
Differences were considered statistically significant for p< 0.05.
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